U.S. Pharmaceutical State Government Affairs: Benchmarking the Resources Required to Ensure Brand Market Access

Non-members: Click here to sign-up for a complimentary tour of
"U.S. Pharmaceutical State Government Affairs: Benchmarking the Resources Required to Ensure Brand Market Access"

Study Overview:
With pricing, political, regulatory and marketing pressures at an all-time high, State Government Affairs functions in the pharmaceutical and biotechnology industries with operations in the U.S. market are continually reassessing levels of human and capital investment needed to support their organizations. Few if any companies can afford not to pay attention to how many people it staffs or how much it invests in this critical function. This benchmarking study was designed to help provide pharmaceutical and biotech State Government Affairs executives and managers that work in the US market assess their investment levels compared to others.

Key Definitions:
For the purposes of this study, State Government Affairs includes the following activities:

• Lobbying: At State Level.
• Medicaid: Includes ADAP, SPAP.
• Advocacy: Financial donations targeting community, professional and patient organizations.
• Public Policy and Federal Government Affairs: Federal Lobbying and Federal Medicare.

• Budget Ranges for State Government Affairs Groups
• Staffing Levels (FTE’s)
• Staff Allocation based on Functional Activities
• Outsourcing Levels
• Budget and FTE Efficiency Measures

• Budget Ranges for State Government Affairs Groups ($US)
• Staffing Levels (FTE’s)
• Staff Allocation By Functional Activity Performed (Accounting and Controlling Services, Commercial Operations and Financial Planning And Analysis)
• % Allocated To Outsourced Services
• Sales Revenue per State Government Affairs FTE
• FTE's per Million $ in Sales
• Budget Employed Per State Government Affairs FTE
• State Government Affairs FTE Employed Per $100 Million In Sales Revenue
• State Government Affairs Budget Expressed As A Percentage Of Sales

Industries Profiled:
Pharmaceutical; Medical Device; Biotech; Health Care


Companies Profiled:
GlaxoSmithKline; Elli Lilly; Roche; Bristol-Myers Squibb; Boehringer Ingelheim; Merck; MedImmune

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.